Tenaya Therapeutics, Inc.
TNYA
$0.89
$0.033.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 7.25% | -16.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.77% | -13.06% | |||
| Operating Income | 0.77% | 13.06% | |||
| Income Before Tax | 0.49% | 12.92% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.49% | 12.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.49% | 12.92% | |||
| EBIT | 0.77% | 13.06% | |||
| EBITDA | 0.65% | 13.30% | |||
| EPS Basic | 7.09% | 13.22% | |||
| Normalized Basic EPS | 9.02% | 13.20% | |||
| EPS Diluted | 7.09% | 13.22% | |||
| Normalized Diluted EPS | 9.02% | 13.20% | |||
| Average Basic Shares Outstanding | 7.16% | 0.34% | |||
| Average Diluted Shares Outstanding | 7.16% | 0.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||